The US National Institutes of Health (NIH) partnered with the pharmaceutical firm, Sanofi, to produce an antibody capable of attacking 99 percent of HIV strains. This new study is made Continue Reading
Close
Guest Authors
- Abraham Becerra- PhenoLogix Scientist
- Allen Misa-Food and Environmental Marketing Manager
- Brian Rivera- Product Manager, Bioseparations
- David C. Kennedy, Ph.D- Business Development Manager
- Jeff Layne, Ph.D.- LC Product Manager and Technical Specialist
- Ramkumar Dhandapani, Ph.D.- Technical Specialist and GC Expert
- Seyed Sadjadi- Senior Scientist